GSDME and colorectal carcinoma: A synthetic farnesoid X receptor agonist (GW4064) could induce BAX/caspase‐3/GSDME‐mediated pyroptosis to promote the efficacy of oxaliplatin so as for enhanced anticancer effects of human CRC.256